Cite

HARVARD Citation

    Tanday, N. et al. (2021). Amplifying the antidiabetic actions of glucagon‐like peptide‐1: Potential benefits of new adjunct therapies. Diabetic medicine. 38 (12), p. n/a. [Online]. 
  
Back to record